Ultragenyx Pharmaceutical Inc. RARE
16.63 USD +0.33 (+2.02%)
At closeNov 4, 2026, 6:04 AM EST
15.90 -0.73 -4.39%
Pre-market · Nov 4, 6:04 AM ET
16.39 Day range 16.99
12.73 52-week range 39.89
- YTD
- -27.70%
- 1 year
- -50.31%
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 673.00M | 560.00M | 434.00M | 363.33M | 351.41M | |
| 564.00M | 483.00M | 389.00M | 335.01M | 335.40M | |
| -535.00M | -536.00M | -569.00M | -650.49M | -383.42M | |
| -575.00M | -569.00M | -607.00M | -707.42M | -454.02M | |
| -5.83 | -6.29 | -8.25 | -10.12 | -6.70 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 421.00M | 174.00M | 213.58M | 132.94M | 307.58M | |
| 1.53B | 1.50B | 1.49B | 1.55B | 1.52B | |
| 1.60B | 1.24B | 1.22B | 1.19B | 599.84M | |
| 1.22B | 910.00M | 934.74M | 907.03M | 393.76M | |
| -87.00M | 248.00M | 275.41M | 352.49M | 922.56M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -466.00M | -414.00M | -475.00M | -380.46M | -338.69M | |
| 236.00M | -18.00M | 168.00M | -291.65M | -195.37M | |
| 478.00M | 399.00M | 388.00M | 501.21M | 118.55M | |
| -6.00M | -7.00M | -44.00M | -116.12M | -73.09M | |
| 252.00M | -35.00M | 81.00M | -171.98M | -416.71M |